Related Experiment Video
Updated: Jul 9, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Narrative Review: Pathogenesis of the Inflammatory Response and Intestinal Flora in Depression
Jia-Wei Zeng1,2, Juan-Li Zhao1, Zhen-Jie Han1
1Laboratory of Medical Molecular and Cellular Biology, College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, 430065, People's Republic of China.
This study explores the link between gut bacteria and inflammation in depression. Improving gut flora may influence inflammatory factors, offering new avenues for depression treatment.
Area of Science:
- Neuroscience
- Immunology
- Microbiology
Background:
- Depression is a complex mental illness with significant public health implications.
- Current depression treatments have limitations, necessitating research into alternative therapeutic targets.
- The inflammatory factor hypothesis and gut flora hypothesis are key areas of investigation in depression pathogenesis.
Purpose of the Study:
- To investigate the interplay between intestinal flora and inflammatory factors in depression.
- To explore novel therapeutic strategies for depression based on modulating gut microbiota and inflammation.
Main Methods:
- Exploration of the role of intestinal flora in depression.
- Analysis of the relationship between gut microbiota and inflammatory factors.
- Investigating the impact of altering gut flora on inflammatory pathways.
Main Results:
- Evidence suggests a connection between gut flora composition and inflammatory responses in depression.
- Modulating the gut microbiota can influence key inflammatory factors implicated in depression.
Conclusions:
- The gut flora plays a significant role in depression pathogenesis, potentially through its interaction with inflammatory pathways.
- Targeting the gut microbiota presents a promising strategy for developing novel depression treatments.
More Related Videos
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Other Disorders of Digestive System

